Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EBIT Growth(%) -80.3033.20180.22-67.21-38.59

What is the latest EBIT Growth ratio of PIRAMAL PHARMA ?

The latest EBIT Growth ratio of PIRAMAL PHARMA is -80.30 based on Mar2026 Consolidated results.
Year EBIT Growth
Mar2026-80.30
Mar202533.20
Mar2024180.22
Mar2023-67.21
Mar2022-38.59

How is EBIT Growth of PIRAMAL PHARMA Trending?

Years EBIT Growth % Change
Mar2026 -80.3
Negative
Mar2025 33.2
-81.58
Mar2024 180.22
Positive
Mar2023 -67.21
Negative
Mar2022 -38.59 -

Other Financial Ratios of PIRAMAL PHARMA


Compare EBIT Growth ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹26,180.0 Cr 0.9% -13.2% -1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,539.0 Cr -1.4% -6.6% 7.3% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 1.2% -2.6% 60% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,251.0 Cr -2% -6.1% 33% Stock Analytics
CIPLA ₹105,290.0 Cr -2.3% -5.8% -13.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,752.6 Cr -1.1% 3.8% -5.5% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

0.9%

-13.2%

-1%

SENSEX

0.8%

-4.8%

-10.5%


You may also like the below Video Courses